Małgorzata Jasiewicz

Małgorzata Jasiewicz


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MOMałgorzata Ostrowska
Małgorzata Ostrowska
ARAlicja Rzepka-Cholasińska
Alicja Rzepka-Cholasińska
Łukasz PietrzykowskiŁukasz Pietrzykowski
Łukasz Pietrzykowski
PMPiotr Michalski
Piotr Michalski
AOAgata Kosobucka- Ozdoba
Agata Kosobucka- Ozdoba
AKAldona Bernadeta Kubica
Aldona Bernadeta Kubica
Up to 80% of COVID-19 survivors experience prolonged symptoms known as long COVID-19. The aim of this study was to evaluate the effects of a multidisciplinary rehabilitation program in patients with long COVID-19. The rehabilitation program was composed of physical training (aerobic, resistance, and breathing exercises), education, and group psychotherapy. After 6 weeks of rehabilitation in 97 patients with long COVID-19, body composition analysis revealed a significant decrease of abdominal fatty tissue (from 2.75 kg to 2.5 kg; p = 0.0086) with concomitant increase in skeletal muscle mass (from 23.2 kg to 24.2 kg; p = 0.0104). Almost 80% of participants reported dyspnea improvement assessed with the modified Medical Research Council scale. Patients’ physical capacity assessed with the 6 Minute Walking Test increased from 320 to 382.5 m (p < 0.0001), the number of repetitions in the 30 s Chair Stand Test improved from 13 to 16 (p < 0.0001), as well as physical fitness in the Short Physical Performance Battery Test from 14 to 16 (p < 0.0001). The impact of fatigue on everyday functioning was reduced in the Modified Fatigue Impact Scale from 37 to 27 (p < 0.0001). Cardiopulmonary exercise test did not show any change. The multidisciplinary rehabilitation program has improved body composition, dyspnea, fatigue and physical capacity in long COVID-19 patients.

14 January 2016 in Heart
Verified
Journal Article
Closed access
PDF file
MJMałgorzata Jasiewicz
Małgorzata Jasiewicz
MMMarcin Moniuszko
Marcin Moniuszko
Dariusz PawlakDariusz Pawlak
Dariusz Pawlak
Małgorzata A. KnappMałgorzata A. Knapp
Małgorzata A. Knapp
MRMalgorzata Rusak
Malgorzata Rusak
Karol Adam KaminskiKarol Adam Kaminski
Karol Adam Kaminski
Objective We evaluated blood concentrations of kynurenine pathway metabolites, natural and induced regulatory T cells (nTreg, iTreg), and Th17 cells in order to examine the activity of the kynurenine pathway and its relation to immune status in patients with pulmonary arterial hypertension (PAH). Methods Plasma concentrations of tryptophan, kynurenine, kynurenic acid, anthranilic acid, and 3-hydroxykynurenine were quantified in 26 patients with PAH (vs 30 healthy controls) at baseline and after 6 months, and assessed them in relation to clinical parameters, frequencies of lymphocyte subsets, and outcome. Results The PAH group presented higher concentrations of tryptophan (52.9 (IQR 46.3–57.5) vs 40.3 (35.2–46.3) µmol/L, p=0.00003), kynurenine 2.8 (2.4−3.4) vs 1.9 (1.5–2.3) µmol/L, p=0.000007), kynurenine/tryptophan ratio (0.051 (0.044–0.064) vs 0.043 (0.039–0.055), p=0.03), iTreg frequencies (10.5 (8.8–13.9)% vs 6.8 (5.2–9.5)%, p=0.002) and iTreg/Th17 (1.73 (1.2–2.8) vs 0.93 (0.61–1.27), p=0.003) together with lower ratios of kynurenic acid/kynurenine, 3-hydroxykynurenine/kynurenine, and anthranilic acid/kynurenine. Kynurenine concentrations and kynurenine/tryptophan ratio correlated positively with iTreg/Th17, and inversely with Th17 subsets, whereas kynurenic acid/kynurenine and anthranilic acid/kynurenine ratios correlated positively with Th17. Adverse outcomes occurred in 9 of 26 patients and they showed higher baseline concentrations of kynurenine (3.6 (2.8–4.3) vs 2.7 (2.1–3.2) µmol/L, p=0.033). Median kynurenine values ≥3.4 µmol/L (67% sensitivity, 94% specificity) identified patients with a worse clinical course. Conclusions PAH is characterised by upregulated tryptophan metabolism and enhanced biosynthesis of kynurenine. Elevated kynurenine concentration is associated with an adverse clinical course. Dysregulated immunity, delineated by Treg-Th17 imbalance, is directly related to diverse activation of the kynurenine pathway, indicating the potential interplay between kynurenines and the immune system in PAH.

1 December 2015 in Cytokine
Verified
Journal Article
Closed access
MJMałgorzata Jasiewicz
Małgorzata Jasiewicz
Małgorzata A. KnappMałgorzata A. Knapp
Małgorzata A. Knapp
EWEwa Waszkiewicz
Ewa Waszkiewicz
KPKatarzyna Ptaszynska
Katarzyna Ptaszynska
ASAnna Szpakowicz
Anna Szpakowicz
Karol Adam KaminskiKarol Adam Kaminski
Karol Adam Kaminski

1 May 2018 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
MMM. Marcinkiewicz-Siemion
M. Marcinkiewicz-Siemion
Michal CiborowskiMichal Ciborowski
Michal Ciborowski
KPK. Ptaszynska-Kopczynska
K. Ptaszynska-Kopczynska
ASAnna Szpakowicz
Anna Szpakowicz
ALA. Lisowska
A. Lisowska
Karol Adam KaminskiKarol Adam Kaminski
Karol Adam Kaminski

1 April 2016 in Cytokine
Verified
Journal Article
Closed access
KPKatarzyna Ptaszynska
Katarzyna Ptaszynska
MMMarta Marcinkiewicz-Siemion
Marta Marcinkiewicz-Siemion
ALAnna Lisowska
Anna Lisowska
EWEwa Waszkiewicz
Ewa Waszkiewicz
MWMarcin Witkowski
Marcin Witkowski
Karol Adam KaminskiKarol Adam Kaminski
Karol Adam Kaminski

1 March 2014 in Cytokine
Verified
Journal Article
Closed access
MJMałgorzata Jasiewicz
Małgorzata Jasiewicz
KKKrzysztof Kowal
Krzysztof Kowal
OKOtylia Kowal-Bielecka
Otylia Kowal-Bielecka
Małgorzata A. KnappMałgorzata A. Knapp
Małgorzata A. Knapp
RSRoman Skiepko
Roman Skiepko
Karol Adam KaminskiKarol Adam Kaminski
Karol Adam Kaminski